Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma
In conclusion, we identified single nucleotide variants in theZBTB46 gene associated with a higher risk of parenchymal haematoma following recombinant tissue-plasminogen activator treatment.
Source: Brain - Category: Neurology Source Type: research
More News: Brain | Disability | Genetics | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Stroke | Study | Thrombolytic Therapy | Thrombosis | Zinc